Kimoto Y
Gan To Kagaku Ryoho. 1986 Dec;13(12):3419-26.
The cytocidal effect of human peripheral blood lymphocytes (PBL's) enhanced by human recombinant interleukin 2 (IL-2) on human colon carcinoma cell line SW1116 was examined in vitro in the presence of plasma from patients with recurrence of colorectal carcinoma. In addition, human recombinant interferons alpha, beta, and gamma were combined to enhance this cytotoxicity of PBL's. Cytotoxicity of PBL's was enhanced by IL-2. Patients' plasma blocked the cytotoxicity of PBL's. Serially added IL-2 was able to maintain the enhanced cytotoxicity of PBL's in the presence of patients' plasma. The mixture of interferons (alpha + beta + gamma, or beta + gamma) directly killed target cells more efficiently than with single use of each interferon or other combinations of interferons. These mixtures of interferons (alpha + beta + gamma, or beta + gamma) also activated cytotoxicity of PBL's. The cytotoxicity of IL-2-activated PBL's was further enhanced by intermittent addition of the interferon mixture.
在存在结直肠癌复发患者血浆的情况下,于体外检测了人重组白细胞介素2(IL-2)增强的人外周血淋巴细胞(PBL)对人结肠癌细胞系SW1116的杀细胞作用。此外,将人重组干扰素α、β和γ联合使用以增强PBL的这种细胞毒性。IL-2增强了PBL的细胞毒性。患者血浆阻断了PBL的细胞毒性。在存在患者血浆的情况下,连续添加IL-2能够维持PBL增强的细胞毒性。干扰素混合物(α+β+γ或β+γ)比单独使用每种干扰素或其他干扰素组合更有效地直接杀伤靶细胞。这些干扰素混合物(α+β+γ或β+γ)也激活了PBL的细胞毒性。通过间歇性添加干扰素混合物,IL-2激活的PBL的细胞毒性进一步增强。